Kalohexis presents dual MC3R/MC4R activation data at ENDO 2026
Lupeng Pharmaceutical's rocbrutinib receives Chinese approval to treat R/R mantle cell lymphoma
Medtronic invests in ICE technology companies to expand cardiac ablation portfolio
Heart Rhythm Society partners with Milestone Pharmaceuticals to offer new SVT patient resources
Haisco receives US FDA approval for anaesthetic Cipepofol
Avacta reports encouraging early efficacy signals for AVA6000 in salivary gland cancer at ASCO 2026
Circio and AaviGen partner to develop next-generation gene therapies for heart disease
Bayer's KERENDIA receives FDA priority review for type 1 diabetes and kidney disease treatment
Artivion completes acquisition of Endospan following FDA approval of NEXUS Aortic Arch System
AstraZeneca wins US approval for Baxfendy as first aldosterone synthase inhibitor for hypertension
GSK's Arexvy gains expanded approval in Japan for at-risk adults aged 18-49
Tenaya Therapeutics reports interim RIDGE-1 data showing reduced arrhythmia burden with TN-401